Deploy personalized medication adherence, lifestyle interventions, side effect monitoring and proven programs that are already live with 5M+ member patients at population scale.
The White House announcement makes it official: GLP-1 medications require integrated digital solutions that combine drug adherence with lifestyle modifications and patient monitoring.
If you are a pharma company, you’re staring at an 18-24 month timeline to build personalized behavior change platforms with no validations on engagement and efficacy at population scale.
While others are still building, CueZen delivers the personalization engine and AI coaching infrastructure your D2C programs require—today
Time-aware interventions that adapt to individual patterns, not calendar reminders that ignore patient behavior
Personalized action plans for nutrition, physical activity, and sleep—proven to deliver 50% lower cardiovascular risk when combined with GLP-1 medications
AI-based coaching with intelligent check-ins based on usage patterns and behavior changes, catching issues before they lead to dropout
CueZen operates as white-labeled infrastructure that enhances your direct-to-consumer experience. Not a separate app. Not a competing platform. Drop-in infrastructure that powers your patient experience.
Conversational AI conducts intelligent health assessments
Explores treatment options and sets realistic expectations
Prepares patients for tele-consultation
Wearable data integration for real-time lifestyle tracking
Personalized coaching based on individual behavioral patterns
Time-aware medication adherence monitoring
AI-based side effect management that adapts to usage patterns
Logistics support for refills and delivery
Re-engagement programs for patients showing dropout signals
Recent studies have shown what’s possible when personalized interventions meet GLP-1 medications. CueZen provides the personalization engine and AI coaching infrastructure that powers these outcomes—already proven at scale with 3 million Singaporeans across metabolic health programs.
Personalized interventions that adapt to individual behavioral patterns and AI-based coaching for proactive side effect management—exactly what CueZen delivers as production-ready infrastructure. Recent clinical evidence backs our integrated approach: